SCHEMBL30838362

SCHEMBL30838362

CC(C)CNCc1cc(C(=O)Nc2cccc(C3(c4nncn4C)CC(C)(C)C3)c2)c(=O)n(CC(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 20/20 0.39
▸ CBLC Q9ULV8 3/20 0.39
▸ CBL P22681 9/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30838155 0.95 CBLB (0.40) CBLBCBLCCBL
SCHEMBL30838328 0.94 CBLB (0.40) CBLBCBLCCBL
SCHEMBL30838130 0.94 CBLB (0.39) CBLBCBLCCBL
SCHEMBL30838152 0.94 CBLB (0.39) CBLBCBLCCBL
SCHEMBL30838213 0.93 CBLB (0.39) CBLBCBLCCBL
SCHEMBL30838322 0.93 CBLB (0.39) CBLBCBLCCBL
SCHEMBL30838216 0.91 CBLB (0.49) CBLBCBLCCBL
SCHEMBL30838159 0.91 CBLB (0.41) CBLBCBLCCBL
SCHEMBL30838318 0.91 CBLB (0.39) CBLBCBLCCBL
SCHEMBL30838235 0.91 CBLB (0.39) CBLBCBLCCBL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 — — EP claimed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 — — WO claimed
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 — — EP disclosed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 — — WO disclosed
Send feedback